Exo Therapeutics appoints Stephanos Ioannidis as Executive Vice President, Drug Discovery and Catherine Scholz as Senior Vice President, Program Management May 19, 2022 Categories: Health Care Tags: Exo Therapeutics
Exo Therapeutics appoints Laura Kiessling to Scientific Advisory Board April 28, 2022 Categories: Health Care Tags: Exo Therapeutics
Exo Therapeutics snags $25M to handle ‘undruggable’ enzymes through their exosites December 16, 2020 Categories: Uncategorized Tags: Exo Therapeutics
